KYMR FY 2020 Earnings — Kymera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

KYMRKymera Therapeutics, Inc.

$7B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$34M+1060.0% YoY

Gross Profit

$34M100.0% margin

Operating Income

-$46M-136.1% margin

Net Income

-$46M-134.0% margin

EPS (Diluted)

$-0.99

Cash Flow

Operating Cash Flow

$88M

Free Cash Flow

$79M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$487M

Total Liabilities

$203M

Stockholders' Equity

$284M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$34M	$3M	+1060.0%
Gross Profit	$34M	$2M	+1513.8%
Operating Income	-$46M	-$42M	-9.7%
Net Income	-$46M	-$41M	-10.4%